What fuels public policy?BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39150.648762.BE (Published 22 March 2007) Cite this as: BMJ 2007;334:599
- Mark H Wilson, director of medical ethics health (email@example.com)
- Health Research Associates, Ottawa, Canada K2B 6J4
Around 60-75% of the millions of drug eluting stents inserted globally are not licensed.1 What has fuelled the high unlicensed use of a device associated with thrombosis? This question was not dealt with by the Food and Drug Administration panel or recent articles on such stents.2 …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial